Anthrax lethal factor represses glucocorticoid and progesterone receptor activity
AUTOR(ES)
Webster, Jeanette I.
FONTE
The National Academy of Sciences
RESUMO
We report here that a bacterial toxin, anthrax lethal toxin (LeTx), at very low concentrations represses glucocorticoid receptor (GR) transactivation in a transient transfection system and the activity of an endogenous GR-regulated gene in both a cellular system and an animal model. This repression is noncompetitive and does not affect ligand binding or DNA binding, suggesting that anthrax lethal toxin (LeTx) probably exerts its effects through a cofactor(s) involved in the interaction between GR and the basal transcription machinery. LeTx-nuclear receptor repression is selective, repressing GR, progesterone receptor B (PR-B), and estrogen receptor α (ERα), but not the mineralocorticoid receptor (MR) or ERβ. GR repression was also caused by selected p38 mitogen-activated protein (MAP) kinase inhibitors, suggesting that the LeTx action may result in part from its known inactivation of MAP kinases. Simultaneous loss of GR and other nuclear receptor activities could render an animal more susceptible to lethal or toxic effects of anthrax infection by removing the normally protective antiinflammatory effects of these hormones, similar to the increased mortality seen in animals exposed to both GR antagonists and infectious agents or bacterial products. These finding have implications for development of new treatments and prevention of the toxic effects of anthrax.
ACESSO AO ARTIGO
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=156265Documentos Relacionados
- Mapping the lethal factor and edema factor binding sites on oligomeric anthrax protective antigen
- Expression of glucocorticoid and progesterone nuclear receptor genes in archival breast cancer tissue
- Proteasome Activity Is Required for Anthrax Lethal Toxin To Kill Macrophages
- Binding of hormone accelerates the kinetics of glucocorticoid and progesterone receptor binding to DNA.
- Decreased glucocorticoid receptor activity following glucocorticoid receptor antisense RNA gene fragment transfection.